Title: Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
Journal: Scientific reports 20150101
Title: Mechanisms and kinetics of thiotepa and tepa hydrolysis: DFT study.
Journal: Journal of molecular modeling 20120801
Title: [Simultaneous determination of six organophosphorous flame retardants in textiles by gas chromatography-tandem mass spectrometry combined with microwave assisted extraction].
Journal: Se pu = Chinese journal of chromatography 20110801
Title: Role for copper in the cellular and regulatory effects of heme-hemopexin.
Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20090601
Title: Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
Journal: British journal of clinical pharmacology 20090101
Title: Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
Journal: Therapeutic drug monitoring 20051201
Title: Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N'-triethylenethiophosphoramide (thiotepa) and N,N',N'-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal: Journal of mass spectrometry : JMS 20040301
Title: Combined-modality treatment of leptomeningeal gliomatosis.
Journal: Neurosurgery 20030201
Title: Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
Journal: Bone marrow transplantation 20021101
Title: Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
Journal: Cancer chemotherapy and pharmacology 20020601
Title: Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin.
Journal: Anti-cancer drugs 20010701
Title: Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy.
Journal: British journal of clinical pharmacology 20010101
